Relmada Therapeutics
-$0.36 (-1.91%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.
About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist, which is a New Chemical Entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders.
CEO
Sergio Traversa
Employees
14
Headquarters
Coral Gables, Florida
Founded
2012
RLMD Key Statistics
Market cap
502.02M
Price-Earnings ratio
—
Dividend yield
—
Average volume
123.76K
High today
$19.84
Low today
$18.15
Open price
$19.09
Volume
117.46K
52 Week high
$40.00
52 Week low
$16.34
Analyst ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
RLMD Earnings
-$2.44
-$1.63
-$0.81
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 24, After Hours